Lantheus Holdings (LNTH) Liabilities from Discontinued Operations (2015 - 2025)
Lantheus Holdings' (LNTH) quarterly Liabilities from Discontinued Operations came in at 22468000.0 in Q4 2025, down 21.35% on a QoQ basis from 28566000.0 in Q3 2025.
Lantheus Holdings (LNTH) Liabilities from Discontinued Operations (2015 - 2025) Analysis & Trends
Lantheus Holdings (LNTH) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 22468000.0 in Q4 2025.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 22468000.0 in Q4 2025; TTM through Dec 2025 was 22468000.0, a N/A change from a year earlier, with the FY2025 full-year figure at 22468000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q4 2025 stood at 22468000.0, down from 28566000.0 in the prior quarter.
- Over the last five years, Liabilities from Discontinued Operations for LNTH reached as high as 29845000.0 in Q2 2025 and fell as low as 22468000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.47 Mn |
| Dec 31, 2025 | 22.47 Mn |
| Sep 30, 2025 | 28.57 Mn |
| Sep 30, 2025 | 28.57 Mn |
| Jun 30, 2025 | 29.85 Mn |
| Jun 30, 2025 | 29.85 Mn |
| Dec 31, 2020 | 1.79 Mn |
| Dec 31, 2020 | 1.79 Mn |
| Dec 31, 2015 | 1.72 Mn |
| Dec 31, 2015 | 1.72 Mn |